OrCam Assistive Smart Cameras For Impaired Sight and Reading Difficulties
Do you or someone you know have difficulty seeing or reading? The most advanced tool for vision loss and reading…
Categories
Latest Blog Posts
- Can Multiple Sclerosis Affect Your Toenails?
- MS and co-morbid autoimmunity
- CIONIC Unveils New Offerings to Address Full Spectrum of Mobility Challenges
- Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
- A 15-year-old hockey player with MS may never experience a symptom, thanks to Colorado research
- Multiple Sclerosis: Can a Blood Test Detect MS Years Before Symptoms Appear? New Research Encouraging
- ‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit’
- Breaking news: Committee favors approval of under-the-skin Ocrevus in Europe
- A Smoldering Process: A New Way of Thinking about Multiple Sclerosis
- PET scans reveal ‘smoldering’ inflammation in patients with MS
- What Are the Physiological Changes of Multiple Sclerosis (MS)?
- How to Spot the Signs of an MS Flare
- Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis (sanofi.com)
- Press Release: TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
- Apr 17, 2024 – Press Release: Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis
- Apr 16, 2024 – Press Release: Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS
- OrCam Assistive Smart Cameras For Impaired Sight and Reading Difficulties
- The Recording Studio Helped This MS Neurologist Through Tough Pandemic Times Now He Has a New Album to Show for It
- Foot Drop: Everything You Need To Know
- Viatris and Mapi Pharma Statement Regarding New Drug Application for GA Depot